Volumetric Absorptive Microsampling as a Sampling Alternative in Clinical Trials and Therapeutic Drug Monitoring During the COVID-19 Pandemic: A Review

References

• FDA. FDA Guidance on Conduct of Clinical Trials of Medical Products during COVID-19 Pandemic Guidance for Industry, Investigators, and Institutional Review Boards. 2020; Available from: https://www.fda.gov/regulatory-information/search.
   Google Scholar
• World Health Organization. y. 2020 Available from: https://www.who.int/health-topics/coronavirus#tab=tab_1. Accessed 37, 2020
   Google Scholar
• CDC. What you should know about COVID-19 to protect yourself and others. Coronavirus Dis. 2020;314937.
   Google Scholar
• ChavezS, LongB, KoyfmanA, LiangSY. Coronavirus Disease (COVID-19): a primer for emergency physicians. Am J Emerg Med. 2020. doi:10.1016/j.ajem.2020.03.036
   Web of Science ®Google Scholar
• Van DoremalenN, BushmakerT, MorrisDH, HolbrookMG, GambleA, WilliamsonBN. Aerosol and surface stability of SARS-CoV-2 as compared with SARS-CoV-1. N Engl J Med. 2020;382(16):1564–1567. doi:10.1056/NEJMc200497332182409
   PubMed Web of Science ®Google Scholar
• JHU. Coronavirus COVID-19 Global Cases. 2020 Available from: https://coronavirus.jhu.edu/map.html. Accessed 1216, 2020.
   Google Scholar
• GordonC, ThesnokovE, FengJ, PorterD, GotteM. The antiviral compound remdesivir potently inhibits RNA-dependent RNA polymerase from Middle East respiratory syndrome coronavirus. J Biol Chem. 2020;295(15):4773–4779. doi:10.1074/jbc.AC120.01305632094225
   PubMed Web of Science ®Google Scholar
• WangM, CaoR, ZhangL, et al. Remdesivir and chloroquine effectively inhibit the recently emerged novel coronavirus (2019-nCoV) in vitro. Cell Res. 2020;30(3):269–271. doi:10.1038/s41422-020-0282-032020029
   PubMed Web of Science ®Google Scholar
• GaoJ, TianZ, YangX. Breakthrough: chloroquine phosphate has shown apparent efficacy in treatment of COVID-19 associated pneumonia in clinical studies. Biosci Trends. 2020;14(1):72–73. doi:10.5582/bst.2020.0104732074550
   PubMed Web of Science ®Google Scholar
• FDA. FDA cautions against use of hydroxychloroquine or chloroquine for COVID-19 outside of the hospital setting or a clinical trial due to risk of heart rhythm problems [Internet]. 2020 Available from: https://www.fda.gov/drugs/drug-safety-and-availability/fda-cautions-against-use-hydroxychloroquine-or-chloroquine-covid-19-outside-hospital-setting-or. Accessed 313, 2020
   Google Scholar
• LondheV, RajadhyakshaM. Opportunities and obstacles for microsampling techniques in bioanalysis: special focus on DBS and VAMS. J Pharm Biomed Anal. 2020;182:113102. doi:10.1016/j.jpba.2020.11310232014628
   PubMed Web of Science ®Google Scholar
• AvataneoV, D’AvolioA, CusatoJ, CantùM, De NicolòA. LC-MS application for therapeutic drug monitoring in alternative matrices. J Pharm Biomed Anal. 2019;166:40–51. doi:10.1016/j.jpba.2018.12.04030609393
   PubMed Web of Science ®Google Scholar
• SpoonerN, AndersonKD, SipleJ, WickremsinheER, XuY, LeeM. Microsampling: considerations for its use in pharmaceutical drug discovery and development. Bioanalysis. 2019;11(10):1015–1038. doi:10.4155/bio-2019-0041.31218897
   PubMed Web of Science ®Google Scholar
• MartialLC, AarnoutseRE, SchreuderMF, HenrietSS, BrüggemannRJM, JoorMA. Cost evaluation of dried blood spot home sampling as compared to conventional sampling for therapeutic drug monitoring in children. PLoS One. 2016;11(12):e0167433. doi:10.1371/journal.pone.0167433.27941974
   PubMed Web of Science ®Google Scholar
• AndersenIKL, RostingC, GjelstadA, HalvorsenTG. Volumetric absorptive MicroSampling vs. other blood sampling materials in LC–MS-based protein analysis – preliminary investigations. J Pharm Biomed Anal. 2018;156:239–246. doi:10.1016/j.jpba.2018.04.03629729637
   PubMed Web of Science ®Google Scholar
• ProttiM, MandrioliR, MercoliniL. Tutorial: volumetric absorptive microsampling (VAMS). Anal Chim Acta. 2019;1046:32–47. doi:10.1016/j.aca.2018.09.00430482302
   PubMed Web of Science ®Google Scholar
• KokMGM, FilletM. Volumetric absorptive microsampling: current advances and applications. J Pharm Biomed Anal. 2018;147:288–296. doi:10.1016/j.jpba.2017.07.02928803682
   PubMed Web of Science ®Google Scholar
• KipAE, KiersKC, RosingH, SchellensJHM, BeijnenJH, DorloTPC. Volumetric absorptive microsampling (VAMS) as an alternative to conventional dried blood spots in the quantification of miltefosine in dried blood samples. J Pharm Biomed Anal. 2017;135:160–166. doi:10.1016/j.jpba.2016.12.01228033553
   PubMed Web of Science ®Google Scholar
• BarcoS, CastagnolaE, MoscatelliA, RudgeJ, TripodiG, CangemiG. Volumetric adsorptive microsampling-liquid chromatography tandem mass spectrometry assay for the simultaneous quantification of four antibiotics in human blood: method development, validation and comparison with dried blood spot. J Pharm Biomed Anal. 2017;145:704–710. doi:10.1016/j.jpba.2017.07.03328806566
   PubMed Web of Science ®Google Scholar
• NikhatS, FazilM. Overview of Covid-19; its prevention and management in the light of Unani medicine. Sci Total Environ. 2020;728:138859. doi:10.1016/j.scitotenv.2020.13885932334163
   PubMed Web of Science ®Google Scholar
• Sinha S, Vohora D. Drug Discovery and Development: An Overview, In: Pharmaceutical Medicine and Translational Clinical Research. Jamia Hamdard University, New Delhi, India. 2017: 19–32. doi:10.1016/B978-0-12-802103-3.00002-X
   Google Scholar
• MeinertCL. Clinical Trials: Design, Conduct, and Analysis. New York: Oxford Univ Press; 2012.
   Google Scholar
• Menteri Kesehatan Republik Indonesia. Peraturan Menteri Kesehatan Republik Indonesia Nomor 72 Tahun 2016 Tentang Standar Pelayanan. Kefarmasian Di Rumah Sakit. 2016;8(3):6–10.
   Google Scholar
• BuclinT, ThomaY, WidmerN, et al. The steps to therapeutic drug monitoring: a structured approach illustrated with imatinib. Front Pharmacol. 2020;11(March):1–10. doi:10.3389/fphar.2020.0017732116689
   PubMed Web of Science ®Google Scholar
• KangJS, LeeMH. Overview of therapeutic drug monitoring. Korean J Intern Med. 2009;24(1):1–10. doi:10.3904/kjim.2009.24.1.119270474
   PubMedGoogle Scholar
• XuY, WoolfEJ, AgrawalNGB, KothareP, PucciV, BatemanKP. Merck’s perspective on the implementation of dried blood spot technology in clinical drug development – why, when and how. Bioanalysis. 2013;5(3):341–350. doi:10.4155/bio.12.32123394700
   PubMed Web of Science ®Google Scholar
• EvansC, ArnoldM, BryanP, et al. Implementing dried blood spot sampling for clinical pharmacokinetic determinations: considerations from the IQ Consortium Microsampling Working Group. AAPS J. 2015;17(2):292–300. doi:10.1208/s12248-014-9695-325488054
   PubMed Web of Science ®Google Scholar
• KotharePA, BatemanKP, DockendorfM, et al. An integrated strategy for implementation of dried blood spots in clinical development programs. AAPS J. 2016;18(2):519–527. doi:10.1208/s12248-015-9860-326857396
   PubMed Web of Science ®Google Scholar
• LinderC, WideK, WalanderM, BeckO, GustafssonLL, PohankaA. Comparison between dried blood spot and plasma sampling for therapeutic drug monitoring of antiepileptic drugs in children with epilepsy: A step towards home sampling. Clin Biochem. 2017;50(7–8):418–424. doi:10.1016/j.clinbiochem.2016.12.00828027888
   PubMed Web of Science ®Google Scholar
• FDA. Guidance for Industry COVID-19: developing Drugs and Biological Products for Treatment or Prevention. 2020 Available from: https://www.fda.gov/regulatory-information/search-fda-guidance-documents/covid-19-developing-drugs-and-biological-products-treatment-or-prevention. Accessed 1216, 2020.
   Google Scholar
• SinghAK, SinghA, SinghR, MisraA. Remdesivir in COVID-19: a critical review of pharmacology, pre-clinical and clinical studies. Diabetes Metab Syndr Clin Res Rev. 2020;14(4):641–648. doi:10.1016/j.dsx.2020.05.018
   PubMed Web of Science ®Google Scholar
• PrincipiN, EspositoS. Chloroquine or hydroxychloroquine for prophylaxis of COVID-19. Lancet Infect Dis. 2020;3099(20):30296. doi:10.1016/S1473-3099(20)30296-6
   Web of Science ®Google Scholar
• NIBIB. NIH begins study to quantify undetected cases of coronavirus infection. 2020 Available from: https://www.niaid.nih.gov/news-events/nih-begins-study-quantify-undetected-cases-coronavirus-infection. Accessed 323, 2020.
   Google Scholar
• LiC, DockendorfM, KowalskiK. Population PK analyses of ubrogepant (MK-1602), a CGRP receptor antagonist: enriching in-clinic plasma pk sampling with outpatient dried blood spot sampling. J Clin Pharm. 2017;58(3):294–303. doi:10.1002/jcph.1021
   PubMed Web of Science ®Google Scholar
• LelongC, WickremsinheE, Filali-AnsaryA, SpoonerN. Training and microsample collection. Microsampling Pharm Bioanal. 2013;15–28. doi:10.4155/EBO.13.440
   Google Scholar
• FDA. Guide to Informed Consent. 2014 Available From: https://www.fda.gov/regulatory-information/search-fda-guidance-documents/informed-consent. Accessed 1216, 2020.
   Google Scholar
• MoeinMM, El BeqqaliA, Abdel-RehimM. Bioanalytical method development and validation: critical concepts and strategies. J Chromatogr B Anal Technol Biomed Life Sci. 2017;1043:3–11. doi:10.1016/j.jchromb.2016.09.028
   PubMed Web of Science ®Google Scholar
• FDA. Bioanalytical Method Validation Guidance for Industry. FDA Guid Ind. 2018:1–22. Available from: http://www.fda.gov/Drugs/GuidanceComplianceRegulatoryInformation/Guidances/default.htmand/orhttp://www.fda.gov/AnimalVeterinary/GuidanceComplianceEnforcement/GuidanceforIndustry/default.htm. Accessed 1216, 2020.
   Google Scholar
• European Medicines Agency. Guideline on Bioanalytical Method Validation. London: European Medicines Agency; 2011 Available from: https://www.ema.europa.eu/en/documents/scientific-guideline/guideline-bioanalytical-method-validation_en.pdf. Accessed 1216, 2020.
   Google Scholar
• DenniffP, ParryS, DopsonW, SpoonerN. Quantitative bioanalysis of paracetamol in rats using volumetric absorptive microsampling (VAMS). J Pharm Biomed Anal. 2015;108:61–69. doi:10.1016/j.jpba.2015.01.05225710904
   PubMed Web of Science ®Google Scholar
• PanchalT, SpoonerN, BarfieldM. Ensuring the collection of high-quality dried blood spot samples across multisite clinical studies. Bioanalysis. 2017;9(2):209–213. doi:10.4155/bio-2016-018927960550
   PubMed Web of Science ®Google Scholar
• TaylorJM, HughesAT, MilanAM, RudgeJ, DavisonAS, RanganathLR. Evaluation of the Mitra microsampling device for use with key urinary metabolites in patients with Alkaptonuria. Bioanalysis. 2018;10(23):1919–1932. doi:10.4155/bio-2018-019330412682
   PubMed Web of Science ®Google Scholar
• LiW, ZhangJ, TseFLS. Strategies in quantitative LC-MS/MS analysis of unstable small molecules in biological matrices. Biomed Chromatogr. 2011;25(1):258–277. doi:10.1002/bmc.157221204113
   PubMed Web of Science ®Google Scholar
• MiaoZ, FarnhamJ, HansonG, PodollT, ReidM. Bioanalysis of emixustat (ACU- 4429) in whole blood collected with volumetric absorptive microsampling by LC-MS/MS. Bioanal. 2015;7(16):2071–2083. doi:10.4155/bio.15.125.
   PubMed Web of Science ®Google Scholar
• ManoY, KitaK, KusanoK. Hematocrit-independent recovery is a key for bioanalysis using volumetric absorptive microsampling devices, MitraTM. Bioanalysis. 2015;7(15):1821–1829. doi:10.4155/bio.15.11126295984
   PubMed Web of Science ®Google Scholar
• YouhnovskiN, Mayrand-ProvencherL, BérubéER, et al. Volumetric absorptive microsampling combined with impact-assisted extraction for hematocrit effect free assays. Bioanalysis. 2017;9(22):1761–1769. doi:10.4155/bio-2017-016729148829
   PubMed Web of Science ®Google Scholar
• SpoonerN, DenniffP, MichielsenL, et al. A device for dried blood microsampling in quantitative bioanalysis: overcoming the issues associated blood hematocrit. Bioanalysis. 2015;7(6):653–659. doi:10.4155/bio.14.31025514576
   PubMed Web of Science ®Google Scholar
• RudgeJ, RanganathLR, DavisonAS, TaylorJM, HughesAT, MilanAM. Evaluation of the Mitra microsampling device for use with key urinary metabolites in patients with Alkaptonuria, Bioanalysis. 1919–1932;10(2018). doi:10.4155/bio-2018-0193
   Google Scholar
• De KeselPMM, LambertWE, StoveCP. Does volumetric absorptive microsampling eliminate the hematocrit bias for caffeine and paraxanthine in dried blood samples? A comparative study. Anal Chim Acta. 2015;881:65–73. doi:10.1016/j.aca.2015.04.05626041521
   PubMed Web of Science ®Google Scholar
• ParkerSL, JasonA, WallisSC. Quantitative bioanalytical validation of fosfomycin in human whole blood with volumetric absorptive microsampling, Bioanalysis. 2015;7:2585–2595. doi:10.4155/bio.15.173
   Google Scholar
• ParkerSL, Guerra ValeroYC, LipmanJ, RobertsJA, WallisSC. Effect of time on recovery of plasma microsamples for the quantitative determination of vancomycin. Bioanalysis. 2016;8:2235–2242. doi:10.4155/bio-2016-015927665940
   PubMed Web of Science ®Google Scholar
• JohnH, WillohS, HörmannP, SiegertM, VondranA, ThiermannH, Novel procedures for analysis of dried plasma using microsampling devices to detect sulfur mustard- albumin adducts for verification of poisoning Mitra devices filter paper Noviplex DUO card, (2016). doi:10.1021/acs.analchem.6b02199.
   Google Scholar
• MercoliniL, ProttiM, CatapanoMC, RudgeJ, SbernaAE. Journal of Pharmaceutical and Biomedical Analysis LC – MS/MS and volumetric absorptive microsampling for quantitative bioanalysis of cathinone analogues in dried urine, plasma and oral fluid samples. J Pharm Biomed Anal. 2016;123:186–194. doi:10.1016/j.jpba.2016.02.01526905673
   PubMed Web of Science ®Google Scholar
• YeZ, GaoH. Evaluation of sample extraction methods for minimizing hematocrit effect on whole blood analysis with volumetric absorptive microsampling. Bioanalysis. 2017;9(4):349–357. doi:10.4155/bio-2015-002828102694
   PubMed Web of Science ®Google Scholar
• CordellRL, ValkenburgTSE, PandyaHC, et al. Quantitation of salbutamol using micro-volume blood sampling – applications to exacerbations of pediatric asthma. J Asthma. 2017:1–9. doi:10.1080/02770903.2017.1402341
   Web of Science ®Google Scholar
• TannaS, AlalaqiA, BerniehD, LawsonG. Clinical Mass Spectrometry Volumetric absorptive microsampling (VAMS) coupled with high-resolution, accurate-mass (HRAM) mass spectrometry as a simplified alternative to dried blood spot (DBS) analysis for therapeutic drug monitoring of cardiovas, Clin. Mass Spectrom. 2018;10:1–8. doi:10.1016/j.clinms.2018.08.002
   Google Scholar
• KovaˇJ, PanicG, NeodoA, et al. Evaluation of a novel micro-sampling device, Mitra TM, in comparison to dried blood spots, for analysis of praziquantel in Schistosoma haematobium - infected children in rural Côte d ’ Ivoire. J Pharm Biomed Anal. 2018;151:339–346. doi:10.1016/j.jpba.2018.01.03029413983
   PubMed Web of Science ®Google Scholar
• ProttiM, CarmenM, GedaliahuB, et al. Journal of Pharmaceutical and Biomedical Analysis Determination of oxycodone and its major metabolites in haematic and urinary matrices: comparison of traditional and miniaturised sampling approaches. J Pharm Biomed Anal. 2018;152:204–214. doi:10.1016/j.jpba.2018.01.04329414014
   PubMed Web of Science ®Google Scholar
• VerheijenRB, ThijssenB, AtrafiF, et al. Validation and clinical application of an LC-MS/MS method for the quantification of everolimus using volumetric absorptive microsampling. J Chromatogr B Anal Technol Biomed Life Sci. 2019;1104:234–239. doi:10.1016/j.jchromb.2018.11.030
   PubMed Web of Science ®Google Scholar
• MarahattaA, MegarajV, McgannPT, WareRE, SetchellKDR. Stable- isotope dilution HPLC – electrospray ionization tandem mass spectrometry method for quantifying hydroxyurea in dried blood samples. 2016;1601:1593–1601. doi:10.1373/clinchem.2016.263715
   Google Scholar
• MoorthyGS, VedarC, ZaneN, ProdellJL, ZuppaAF. Development and validation of a volumetric absorptive microsampling assay for analysis of voriconazole and voriconazole N-oxide in human whole blood. J Chromatogr B Anal Technol Biomed Life Sci. 2019;1105:67–75. doi:10.1016/j.jchromb.2018.12.007
   PubMed Web of Science ®Google Scholar
• JonesC, DunseathGJ, LemonJ, LuzioSD. Microsampling collection methods for measurement of C-peptide in whole blood. 2018:1–5. DOI:10.1177/1932296818763464
   Google Scholar